Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels

Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis

(2011) Jwa-Kyung Kim et al.   ATHEROSCLEROSIS

Plasma S100A12 Level Is Associated with Cardiovascular Disease in Hemodialysis Patients

(2011) Y. Shiotsu et al.   Clinical Journal of the American Society of Nephrology

Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients

(2011) Mohamed M. NasrAllah et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Serum S100A12 (EN-RAGE) Levels in Patients with Decreased Renal Function and Subclinical Chronic Inflammatory Disease

(2011) Oskar Zakiyanov et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)

(2011) D. Leonardis et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients

(2010) A. Nakashima et al.   Clinical Journal of the American Society of Nephrology

RAGE and cardiovascular disease

(2010) Chi Young Shim   Frontiers in Bioscience-Landmark

Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease

(2009) Nitin Mahajan et al.   ATHEROSCLEROSIS

Vascular Calcification and ESRD: A Hard Target

(2009) I. Bhan et al.   Clinical Journal of the American Society of Nephrology

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease

(2009) Giuseppina Basta et al.   KIDNEY INTERNATIONAL

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

(2009) Yueh-Sheng Chen et al.   ARTHRITIS RESEARCH & THERAPY

Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

(2008) Francesca Tentori et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis

(2008) Yasukiyo Mori et al.   AMERICAN JOURNAL OF NEPHROLOGY